Send Inquiry

Request To Call Back

500mg Reditux Rituximab Injection

Name: 500mg Reditux Rituximab Injection
Brand: JAYPEE PHARMACARE
Price: 28250.0 INR
Availability: InStock

Price 28250.0 INR/ Piece

Get a Price/Quote

MOQ : 10 Pieces

500mg Reditux Rituximab Injection Specification

Salt Composition
Rituximab

Packaging Type
Vial

Pacakaging (Quantity Per Box)
1 Vial Per Box

Life Span
24 Months from the date of manufacturing

Indication
Non-Hodgkins Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis

Brand Name
Reditux

Origin of Medicine
India

Dosage Form
Injection

Drug Type
Biological/Monoclonal Antibody

Ingredients
Rituximab 500 mg

Physical Form
Lyophilized Powder for Injection

Function
Monoclonal Anti-CD20 Antibody; targets and destroys CD20-positive B cells

Recommended For
Patients with Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis

Dosage
As prescribed by the physician, usually administered intravenously

Dosage Guidelines
Refer to physician or product insert for detailed dosage and administration guidelines.

Suitable For
Adults

Storage Instructions
Store at 2C-8C. Do not freeze. Protect from light.

Caution
Administer under the supervision of a qualified physician experienced in cancer chemotherapy

Appearance
White to off-white lyophilized cake or powder

Prescription
Prescription Only Medicine

Reconstitution
To be reconstituted with sterile water for injection as per the guideline

Side Effects
Infusion reactions, fever, chills, infections, neutropenia, nausea

Administration Route
Intravenous Infusion only

Marketed By
Dr. Reddy's Laboratories

Therapeutic Class
Anti-cancer (Antineoplastic) Agent

500mg Reditux Rituximab Injection Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 500mg Reditux Rituximab Injection

Strength	500 mg
Packaging Size	50 ml
Brand	Reditux
Manufacturer	Dr. Reddy's
Packaging Type	Box
Treatment	Cancer
Composition	Rituximab

Reditux (rituximab) 500 mg injection is a medication used to treat certain types of cancer and autoimmune diseases. It is primarily used for non-Hodgkin's lymphoma and chronic lymphocytic leukemia, as well as conditions like rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Rituximab works by targeting and depleting specific immune cells involved in these conditions.

Advanced Therapy for B-cell Disorders

Reditux (Rituximab) 500mg Injection is an established monoclonal antibody therapy for treating various B-cell associated malignancies and autoimmune conditions. By targeting CD20-positive B cells, it helps in controlling abnormal growth or immune activity, thus contributing to better disease management.

How is Reditux Administered?

Reditux requires careful preparation and administration. The lyophilized powder must be reconstituted with sterile water as per guidelines and administered as an intravenous infusion under medical supervision. Dosage schedules depend on the condition being treated and individual patient factors, always determined by a qualified physician.

Safety and Storage Guidelines

This medication is intended for use only by a healthcare professional in a clinical setting. It should be stored in a refrigerator (2C-8C), protected from light, and never frozen. Patients should not handle or self-administer, ensuring every step is managed by trained staff.

FAQ's of 500mg Reditux Rituximab Injection:

Q: How is Reditux (Rituximab) Injection prepared and administered?

A: Reditux is supplied as a lyophilized powder that must be reconstituted with sterile water for injection following the product guidelines. Once prepared, it is administered as an intravenous infusion by healthcare professionals in a controlled hospital or clinic environment.

Q: What conditions is Reditux used to treat?

A: Reditux is recommended for adults with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis. Its usage and dosage depend on the specific medical indication and patient profile.

Q: When should Reditux be given, and who can receive it?

A: Reditux is usually given on specific schedules as prescribed by the attending physician, tailored to the disease being managed. It is suitable for adult patients, and not recommended for children unless specifically indicated by a specialist.

Q: Where should Reditux be stored prior to use?

A: Reditux must be stored in a refrigerator at a temperature between 2C and 8C, away from light. It should never be frozen. Only authorized healthcare personnel should manage storage and handling.

Q: What are the common side effects associated with Reditux?

A: Patients may experience infusion reactions such as fever, chills, nausea, infections, or blood cell count changes like neutropenia. All patients will be closely monitored during and after infusion to manage any adverse effects promptly.

Q: What benefits can patients expect from Reditux therapy?

A: By targeting and destroying CD20-positive B cells, Reditux can help control cancer cell growth in lymphomas and leukemia, and reduce disease activity in autoimmune conditions, leading to improved clinical outcomes and potentially longer remission periods.

Q: Is Reditux available without a prescription?

A: No, Reditux is a prescription-only medicine and must be used strictly under the supervision of a qualified physician experienced in cancer chemotherapy, in adherence to official guidelines.

Tell us about your requirement